Women Health’s
Commercial Sprint
A six-week working sprint for #Femtech founders who are ready to move from validated product to a fundable, scalable commercial model.
Seats available: 6 / 10The Gap
Most women's health companies stall in the same place.
01
The payer question is still open
Who actually pays — consumer, employer, insurer, or clinic — shapes everything: the model, the channel, the pricing, the pitch. Most founders haven't answered it precisely enough.
02
The business model doesn't hold at scale
Early traction masks structural unit economics problems. What works at 50 customers breaks at 500. Building more before fixing this compounds the problem.
03
The investor story is missing a commercial spine
Science and mission aren't enough. Investors need to see a clear market, a defensible model, and a go-to-market that doesn't rely on hope as a strategy.
The Sprint
Six weeks. One company at a time. Real output.
6 Weeks
Fixed sprint, clear output
1:1
Direct access, not a cohort programme
Concrete Deliverables that work for you
01
Discovery
Where the business actually stands — payer clarity, unit economics, positioning gaps
>
02
Business Model Design
Revenue mechanics, pricing, what the model looks like when it works at scale
>
03
Positioning & GTM
Channel prioritisation, first 90 days plan, what "traction" looks like for your model
>
04
Investor & Partner narrative
The commercial story that makes investors and distribution partners take you seriously
What to ExpectOne focused subject.
Curated room.
Most health innovation conversations happen in silos. Founders talk to founders. Pharma talks to pharma. The conversations that would actually move things forward — where both sides speak honestly about what's blocking progress — almost never happen.
The Health Innovation Table is built around one principle: put the right people in the same room, on the same specific topic, with enough structure to go somewhere real. No panel. No pitches. No slides.
A working conversation with Chatham House rules and a deliberately curated mix — founders, pharma innovation leads, investors, and researchers. The kind of room that takes years of relationships to make possible.
Who is it for
Great Fit
Not For You
-
Non-pitch environment. The conversation you can't have at a conference.
-
What blocks progress, heard directly from the people making those decisions.
-
At a similar stage, working through the same commercial challenges.
What you’ll leave with
01
Top Industry Insights from the ecosystem
Whether you're a founder, a pharma lead, or an investor — an honest cross-stakeholder conversation tells you things that months of desk research and pitch meetings don't. You leave knowing something specific you didn't know before.
02
Answer to questions you can't ask directly.
The room gives you 90 minutes with people who are normally on the other side of a negotiation, an evaluation, or a pitch. You can ask what's actually blocking progress — and get a real answer.
03
Session synthesis note in your inbox
A short written summary of what the room discussed — key observations, where people agreed, where they didn't. No names, no direct quotes. Clear enough to share with your team.
The Format
Designed to become meaningful.
Framing
00:00
Context, objectives, and quick introductions. Pre-read distributed five days in advance so participants come prepared and engaged.Opening provocation
00:10
One invited voice, 10 minutes, no slides. A specific counterintuitive perspective. Sets the tone for what follows.Round 1
00:20
Three prepared questions, facilitated. Everyone has a voice. No single person dominates.Round 2
01:00
Focus shifts from diagnosis to what could actually be done differently.Closing
01:25
Three key observations. One final thought from each attendee. Ends sharp — no drag.Frequently Asked Questions
-
Yes. Chatham House rules, strictly. Nothing said will be recorded or attributed publicly. You'll receive a short synthesis document from Mik afterwards — observations only, no attribution.
-
The full attendee list is shared with confirmed attendees 48 hours before. The composition: 10 people across founders, pharma innovation leads, investors, and researchers. Every seat is curated.
-
Yes, immediately. Email mik@hcollective.co with your company details and a €99 invoice will be sent within the hour. We accept bank transfer or card.
-
Full refund if you cancel more than 48 hours before the session. No refund after that — the seat will have been held and others turned away.
-
Email us and you'll be on the priority list for the next edition. The Health Innovation Table runs quarterly — next session is planned for Q3 2026.
-
Sponsorship for future editions is available. This first session is attendee-funded to protect the independence of the conversation. Reach out: hello@hcollective.co.